Harvard University’s longstanding ties to China have come under fire as the Trump administration accuses the institution of enabling Chinese Communist Party (CCP) influence. Citing alleged antisemitism and collaboration with Beijing, the administration moved to revoke Harvard’s ability to enroll foreign students—nearly 20% of whom were Chinese nationals in 2024. A federal judge has temporarily blocked the order after Harvard filed a lawsuit.
The White House claims Harvard ignored CCP-linked harassment and failed to safeguard national security. Critics, including former Harvard President Larry Summers, say the move undermines U.S. global leadership in education. Harvard maintains the ban punishes free speech and reflects unconstitutional retaliation.
Republican lawmakers have long raised concerns that China uses elite institutions like Harvard to access sensitive technologies and suppress dissent. Harvard’s engagements with China, including public health training provided to the Xinjiang Production and Construction Corps (XPCC)—sanctioned by the U.S. for human rights abuses—have intensified scrutiny.
In 2014, Harvard received a $350 million donation from Hong Kong businessman Ronnie Chan, linked to the China-United States Exchange Foundation, a registered foreign principal under U.S. law. Separately, former Harvard professor Charles Lieber was convicted in 2021 for lying about Chinese affiliations under the Trump-era China Initiative, which was later discontinued under Biden due to concerns about racial profiling.
Incidents like a Chinese exchange student physically removing a protester at a 2024 Harvard event featuring China’s ambassador have further fueled the controversy. In April, the Education Department demanded records on Harvard’s foreign funding over discrepancies in reported donations.
Human rights expert Yaqiu Wang criticized the broad ban on foreign students, saying it harms U.S. interests. While national security concerns are valid, she argues the response is excessive and counterproductive.


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
NATO to Discuss Strengthening Greenland Security Amid Arctic Tensions
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
Federal Reserve Faces Subpoena Delay Amid Investigation Into Chair Jerome Powell
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
U.S. Condemns South Africa’s Expulsion of Israeli Diplomat Amid Rising Diplomatic Tensions
U.S. to Begin Paying UN Dues as Financial Crisis Spurs Push for Reforms
U.S. Justice Department Removes DHS Lawyer After Blunt Remarks in Minnesota Immigration Court
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
ICE Blocked From Entering Ecuador Consulate in Minneapolis During Immigration Operation
Trump Administration Sued Over Suspension of Critical Hudson River Tunnel Funding 



